Clinical trial / 2013
Chlorella supplementation was linked to decreased ALT levels in chronic hepatitis C.
Eighteen adults with chronic hepatitis C virus genotype 1 took daily oral Chlorella for 12 weeks. Following supplementation, 84.61% of participants experienced a significant drop in alanine aminotransferase levels. Reductions in aspartate aminotransferase in 69.23% of patients and reductions in viral RNA in 69.23% were not statistically significant.
- Study type
- Controlled clinical trial
- Who was studied
- 18 adults with chronic hepatitis C virus genotype 1
- What was measured
- ALT, AST, and HCV RNA levels
THE PAPER
Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection.
Azocar J, Diaz A. World J Gastroenterol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.